Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Seeger

Showing results (691-700 of 704) with videos related to

Pageof 71
Sort By:
Circulation Research|April 19, 2024
GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary HypertensionXuran Chu, Vahid Kheirollahi, Arun Lingampally, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2024
Evaluation of a medical student-delivered smoking prevention program utilizing a face-aging mobile app for secondary schools in Germany: The Education Against Tobacco cluster-randomized controlled trialTitus J Brinker, Eva I Krieghoff-Henning, Janina L Suhre, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
Nature Metabolism|July 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Nature Metabolism|July 23, 2020
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
JMIR Research Protocols|April 12, 2019
Process Evaluation of a Medical Student-Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized TrialTitus Josef Brinker, Fabian Buslaff, Janina Leonie Suhre, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial HypertensionJoshua Hodgson, Emilia M Swietlik, Richard M Salmon, et al.
Pageof 71

Showing results (691-700 of 704) with videos related to

Sort By:
Pageof 71
Circulation Research|April 19, 2024
GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary HypertensionXuran Chu, Vahid Kheirollahi, Arun Lingampally, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2024
Evaluation of a medical student-delivered smoking prevention program utilizing a face-aging mobile app for secondary schools in Germany: The Education Against Tobacco cluster-randomized controlled trialTitus J Brinker, Eva I Krieghoff-Henning, Janina L Suhre, et al.
Chest|March 20, 2024
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Henning Gall, Meike Fünderich, et al.
Nature Metabolism|July 23, 2020
NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Nature Metabolism|July 23, 2020
Author Correction: NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPDMichael Seimetz, Natascha Sommer, Mariola Bednorz, et al.
Pulmonary Circulation|August 29, 2022
Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centersRaphael W Majeed, Martin R Wilkins, Luke Howard, et al.
American Journal of Respiratory and Critical Care Medicine|August 7, 2025
Hemodynamics and Phosphodiesterase-5 Inhibitor Treatment Associated with Survival in ILD-PH: A PVRI GoDeep Meta-Registry AnalysisAthiththan Yogeswaran, Paul M Hassoun, Khaled Saleh, et al.
JMIR Research Protocols|April 12, 2019
Process Evaluation of a Medical Student-Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized TrialTitus Josef Brinker, Fabian Buslaff, Janina Leonie Suhre, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial HypertensionJoshua Hodgson, Emilia M Swietlik, Richard M Salmon, et al.
Pageof 71